WISE recommendations to ensure the safety of injections in diabetes

Diabetes and Metabolism

Volumn 38, Issue SUPPL. 1, 2012, Pages

  Strauss, K ^a  

^a BD   (Belgium)

Author keywords

Bloodborne pathogens; EU directive; Fingerstick injury; Health care worker safety; Hepatitis B; Hepatitis C; HIV; Insulin injection; Muco cutaneous exposure; Review

Indexed keywords

ARTICLE; DIABETES MELLITUS; DRUG LEGISLATION; EUROPEAN UNION; EVIDENCE BASED PRACTICE; HUMAN; INJURY; MEDICAL CARE; MEDICAL EDUCATION; MEDICAL ETHICS; MEDICAL LITERATURE; PATIENT SAFETY; PRACTICE GUIDELINE; RISK ASSESSMENT;

DIABETES MELLITUS; EVIDENCE-BASED MEDICINE; GUIDELINES AS TOPIC; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; INJECTIONS; NEEDLESTICK INJURIES; SAFETY MANAGEMENT;

EID: 84856424403     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/S1262-3636(12)70975-8     Document Type: Article

References (52)

1. Council Directive 2010/32/EU, Official Journal of the European Union, L134/71.
2. 34:0066:0072:EN:PDF. http://eurlex.europa.eu/LexUriServ/LexUriServ.do%3Furi=OJ%3AL%3A2010%3A1.
3. Tarantola A., Abiteboul D., Rachline A. Infection risks following accidental exposure to blood or body fluids in health care workers: A review of pathogens transmitted in published cases. Am J Infect Control 2006, 34:367-375.
4. EU Commission for Employment, Social Affairs and Inclusion, New legislation to reduce injuries for 3.5 million healthcare workers in Europe, 8th March 2010.
5. Perry J, Parker G, Jagger J EPINet Report: 2004 Percutaneous Injury Rate. International Healthcare Worker Safety center, August 2007. Available at: http://healthsystem.virginia.edu/internet/safetycenter/.
6. Kiss P., De Meester M., Braeckman L. Needle stick injuries in nursing homes: The prominent role of insulin pens. Infect Control Hosp Epidemiol 2008, 29:1192-1194.
7. Lee J.M., Botteman M.F., Nicklasson L., Cobden D., Pashos C.L. Needle stick injury in acute care nurses caring for patients with diabetes mellitus: a retrospective study. Curr Med Res Opin 2005, 21:741-747.
8. Demir M., Serin E., Göktürk S., Ozturk N.A., Kulaksizoglu S., Ylmaz U. The prevalence of occult hepatitis B virus infection in type 2 diabetes mellitus patients. Eur J Gastroenterol Hepatol 2008, 20:668-673.
9. Simó R., Hernández C., Genescà J., Jardí R., Mesa J. High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 1996, 19:998-1000.
10. Mondy K., Overton E.T., Grubb J., Tong S., Seyfried W., Powderly W., Yarasheski K. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population. Clin Infect Dis 2007, 44:726-734.
11. Sibanda T. Needle stick injuries are a preventable healthcare hazard. BJOG 2008, 115:1579.
12. Council Directive 2010/32/EU, Official Journal of the European Union, L134/71, http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:134:0066:0072:EN:PDF.
13. EU Commission for Employment, Social Affairs and Inclusion, New legislation to reduce injuries for 3.5 million healthcare workers in Europe, 8th March 2010.
14. Article 3.2 says that where risk cannot be eliminated the employer shall take appropriate measures to minimise the risks. Appropriate measures to minimise the risks would include the provision by employers of safer needle devices. (Cf. NHS Employers, Implementation advice on sharps agreement, 12th October 2010) The Directive specifically requires: "eliminating the unnecessary use of sharps by implementing changes in practice and on the basis of the results of the risk assessment, providing medical devices incorporating safety-engineered protection mechanisms" Council Directive 2010/32/EU, Official Journal of the European Union, L134/71 and Council Directive 2010/32/EU, Official Journal of the European Union, L134/69.
15. Watterson L. Sharp Thinking. Nursing Standard 2005, 20:20-22. October.
16. PHASE study group (Italy) Rischio biologico e punture accidentali negli operatori sanitari. Series Lauri Edizioni, Milano 2001 and 2003. ISBN 88 86867 08 5; 88 86867 12 3.
17. Wittmann A., Köver J., Hofmann F., Kralj N. übertragene Blutvolumina nach Nadelstichverletzungen an s.c. Kanulen, Dokumentations-CDROM uber 49. Jahrestagung der DGAUM 2009, 382-384.
18. CDC Case-Control Study of HIV Seroconversion in Health-Care Workers After Percutaneous Exposure to HIV-Infected Blood --France, United Kingdom, and United States, January 1988-August 1994. MMWR 1995; 44:929-33.
19. Yazdanpanah Y., DeCarli G., Migueres B., Lot F., Campins M., Colombo C., et al. Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study. Clin Infect Dis 2005, 41:1423-1430.
20. Adams D., Elliott T.S.J. Impact of safety needle devices on occupationally acquired needle stick injuries: a four-year prospective study. J Hosp Infect 2006, 64:50-55.
21. Tarantola A., Golliot F., Astagneau P., Fleury L., Brucker G., Bouvet E. CCLIN Paris-Nord Blood and Body Fluids (BBF) Exposure Surveillance Taskforce. Four-year surveillance from the Northern France network. Am J Infect Control 2003, 31:357-363.
22. Cullen B.L., Genasi F., Symington I., et al. Potential for reported needle stick injury prevention among healthcare workers in NHS Scotland through safety device usage and improvement of guideline adherence: an expert panel assessment. J Hosp Infect 2006, 63:445-451.
23. Mendelson MH, Lin-Chen BY, Finkelstein-Blond L, Bailey E, Kogan G. Evaluation of a Safety IV Catheter (IVC) (Becton Dickinson, INSYTE™ AUTOGUARD™): Final Report Eleventh Annual Scientific Meeting Society for Healthcare Epidemiology of America, 2001 SHEA, Toronto, Canada.
24. Louis N., Vela G. Groupe Projet. évaluation de l'efficacité d'une mesure de prévention des accidents d'exposition au sang au cours du prélèvement de sang veineux. Bulletin épidémiologique Hebdomadaire 2002, 51:260-261.
25. Lamontagne F., Abiteboul D., Lolom I., Pellissier G., Tarantola A., Descamps J.M., Bouvet E. Role of safety-engineered devices in preventing needlestick injuries in 32 French hospitals. Infect Control Hosp Epidemiol 2007, 28:18-23.
26. Tuma S.J., Sepkowitz K.A. Efficacy of Safety-engineered device implementation in the prevention of percutaneous injuries: a review of published studies. Clin Infect Dis 2006, 42:1159-1170.
27. Adams D., Elliott T.S. Safety-engineered needle devices: evaluation prior to introduction is essential. J Hosp Infect 2011, 79:174-175.
28. Based on OSHA documents available at: http://www.osha.gov/index.html.
29. Sonoki K., Yoshinari M., Iwase M., Tashiro K., Iino K., Wakisaka M., et al. Regurgitation of blood into insulin cartridges in the pen-like injectors. Diabetes Care 2001, 24:603-604.
30. Costigliola V, Letondeur C, Frid A, Strauss K. Needlestick injuries in European hospital nurses giving injections to patients with diabetes 2012 (published in this same supplement).
31. Adams D., Elliott T.S.J. A comparative user evaluation of three needle protective devices. Br J Nurs 2003, 12:470-474.
32. Kreugel G., Keers J.C., Jongbloed A., Verweij-Gjaltema A.H., Wolffenbuttel B.H.R. The influence of needle length on glycemic control and patient preference in obese diabetic patients. Diabetes 2009, 58:A117.
33. Kreugel G., Beijer H.J.M., Kerstens M.N., ter Maaten J.C., Sluiter W.J., Boot B.S. Influence of needle size for SC insulin administration on metabolic control and patient acceptance. Europ Diab Nursing 2007, 4:1-5.
34. Schwartz S., Hassman D., Shelmet J., Sievers R., Weinstein R., Liang J., Lyness W. A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge × 6mm needle versus a 29 gauge × 12.7mm needle in obese patients with diabetes mellitus. Clin Ther 2004, 26:1663-1678.
35. Hirsch L., Klaff L., Bailey T., Gibney M., Albanese J., Qu S., Kassler-Taub K. Comparative glycemic control, safety and patient ratings for a new 4mm\32G insulin pen needle in adults with diabetes. Curr Med Res Opin 2010, 26:1531-1541.
36. Strauss K., Hannet I., McGonigle J., Parkes J.L., Ginsberg B., Jamal R., Frid F. Ultra-short (5mm) insulin needles: trial results and clinical recommendations. Pract Diabetes Intern 1999, 6:22-25.
37. Lo Presti D, Ingegnosi C, Strauss K. Skin and subcutaneous thickness at injecting sites in children with diabetes: ultrasound findings and injecting recommendations. J Pediatr 2012 (in press).
38. Birkebaek N.H., Solvig J., Hansen B., et al. A 4-mm needle reduces the risk of intramuscular injections without increasing backflow to skin surface in lean diabetic children and adults. Diabetes Care 2008, 31:e65.
39. WHO Patient Safety Curriculum Guide Multi-professional Edition World Health Organization 2011. Available on the WHO web site. http://www.who.int/.
40. Prüss-üstün A, Rapiti E, Hutin Y. Sharps Injuries: Global burden of disease from sharps injuries to health-care workers. Environmental Burden of Disease Series, No. 3. World Health Organization, Geneva 2003. Available at: http://whqlibdoc.who.int/publications/2003/9241562463.pdf.
41. Brusaferro S., Calligaris L., Farneti F., Gubian F., Londero C., Baldo V. Educational programmes and sharps injuries in health care workers. Occup Med (Lond) 2009, 59:512-514.
42. Jagger J., Perry J., Gomaa A., Phillips E.K. The impact of U.S. policies to protect healthcare workers from bloodborne pathogens: The critical role of safety-engineered devices. J Infect Pub Health 2008, 1:62-71.
43. Council Directive 2010/32/EU, Official Journal of the European Union, L134/71 and Council Directive 2010/32/EU, Official Journal of the European Union, L134/69.
44. Adams D. To the point: needlestick injuries, risks, prevention and the law. Brit J Nurs 2011, 20:3356-3359.
45. Technical Rules for Biological Agents (TRBA 250 Point 4.1.1.4) published by the German Bundesanstalt für Arbeitsschutz und Arbeitsmedizin (Federal Institute for Occupational Safety and Health, see). http://www.baua.de/.
46. Vos D., Gotz H.M., Richardus J.H. Needlestick injury and accidental exposure to blood: The need for improving the hepatitis B vaccination grade among health care workers outside the hospital. Am J Infect Control 2006, 34:610-612.
47. Larmuseau D. Safety products, for everyone's (financial) benefit (Les produits de sécurité, un avantage (financier) pour tous). Study sponsored by and used with kind permission of UNAMEC, The Belgian Association for producers and/or distributors of medical devices.
48. Guillaudin M, Tortolano L, Bouche V, Jumel C, Borget I, Tilleul P. Cost-effectiveness of safe needles for insulin pen versus standard needles in the prevention of occupational blood exposure. Presentation at the 40th Symposium on Clinical Pharmacy of the European Society of Clinical Pharmacy. Dublin, Ireland. 18-21 October 2011.
49. Armadans Gil L., Fernandez Cano M.I., Albero Andres I., Angles Mellado M.L., Sanchez Garcia J.M., Campins Marti M., et al. Safety-engineered devices to prevent percutaneous injuries: cost-effectiveness analysis on prevention of high-risk exposure Gac Sanit 2006, 5:374-381.
50. Glenngard A.H., Persson U. Costs associated with sharps injuries in the Swedish health care setting and potential cost savings from needle-stick prevention devices with needle and syringe Scand J Infect Dis 2009, 41:96-302.
51. Workman R.G.N. Safe injection techniques. Prim Hlth C 2000, 10:43-50.
52. Bain A., Graham A. How do patients dispose of syringes?. Pract Diab Int 1998, 15:19-21.